Allosteric Interactions of Staurosporine and Other Indolocarbazoles withN-[methyl-3H]Scopolamine and Acetylcholine at Muscarinic Receptor Subtypes: Identification of a Second Allosteric Site
Authors:
- 1 July 2000
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 58 (1) , 194-207
Abstract
We have studied the interactions of five indolocarbazoles withN-[methyl-3H]scopolamine (NMS) and unlabeled acetylcholine at M1-M4 muscarinic receptors, using equilibrium and nonequilibrium radioligand binding studies. The results are consistent with an allosteric model in which the primary and allosteric ligands bind simultaneously to the receptor and modify each other9s affinities. The compounds were generally most active at M1 receptors. [3H]NMS binding was enhanced by staurosporine, KT5720, and KT5823 at M1 and M2 receptors, and by K-252a at M1 receptors. Gö 7874 reduced [3H]NMS affinity by up to threefold for all subtypes. A range of cooperative effects with acetylcholine was seen, and, at the M1 receptor, KT5720 had a log affinity of 6.4 and enhanced acetylcholine affinity by 40%. The compounds inhibited the dissociation of [3H]NMS to different extents across the receptor subtypes, with the largest effects at M1 receptors. In equilibrium binding studies the inhibitory potency of gallamine at M1 receptors was not affected by KT5720, indicating that these agents bind to two distinct allosteric sites and have neutral cooperativity with each other. In contrast, gallamine and staurosporine had a negatively cooperative or competitive interaction at M1 receptors. Similarly, the potency and relative effectiveness of KT5720 for inhibiting [3H]NMS dissociation from M1 receptors were not affected by gallamine or brucine, but were affected in a complex manner by staurosporine. These results demonstrate that there are at least two distinct allosteric sites on the M1 receptor, both of which can support positive cooperativity with acetylcholine.Keywords
This publication has 11 references indexed in Scilit:
- Allosteric modulators of ligand binding to muscarinic acetylcholine receptorsDrug Discovery Today, 1998
- Subtype-Selective Positive Cooperative Interactions between Brucine Analogues and Acetylcholine at Muscarinic Receptors: Radioligand Binding StudiesMolecular Pharmacology, 1998
- ALLOSTERIC INTERACTIONS AT MUSCARINIC CHOLINOCEPTORSClinical and Experimental Pharmacology and Physiology, 1998
- Positive Cooperativity of Acetylcholine and Other Agonists with Allosteric Ligands on Muscarinic Acetylcholine ReceptorsMolecular Pharmacology, 1997
- Divergent Modes of Action among Cationic Allosteric Modulators of Muscarinic M2 ReceptorsMolecular Pharmacology, 1997
- Selective allosteric enhancement of the binding and actions of acetylcholine at muscarinic receptor subtypesLife Sciences, 1997
- Allosteric regulation of the binding of [3H]acetylcholine to m2 muscarinic receptorsBiochemical Pharmacology, 1996
- Estimation of competitive antagonist affinity from functional inhibition curves using the Gaddum, Schild and Cheng‐Prusoíf equationsBritish Journal of Pharmacology, 1993
- K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinasesBiochemical and Biophysical Research Communications, 1987
- Staurosporine, a potent inhibitor of phospholipidCa++dependent protein kinaseBiochemical and Biophysical Research Communications, 1986